Alldus’ Post

This week, the Alldus podcast hosted Fog Chief Data Officer, Brandon Allgood, Ph.D., for a discussion on his career applying machine learning and large-scale computational methods to improve human health. The conversation highlighted Brandon’s industry leadership and expertise in this important discipline and how we’re combining biology and chemistry with data science advances to revolutionize the discovery and development of transformational medicines.    Our data science efforts are robust and growing at Fog, and we’re building the team to support that growth. We’re currently hiring for the following roles on Brandon’s team:     - Sr. Scientist, Machine Learning   - Principal Data Product Engineer  - Sr. Data Scientist, Cheminformatics    Learn more about these positions here: https://bit.ly/3VSwmAx     #TeamFogPharma #BiotechJobs #machinelearning #artificialintelligence #AI  

Harnessing the power of AI and ML is one of the most important themes in biology today

"DeepMirror is making AI for drug discovery as accesible as browsing the web". Go have a listen if you'd like to learn more about the work we're doing in the larger context of the AI revolution!

Latest episode of Data in Biotech is now live! 🎙️ This week, Ross Katz sat down with Michael Nally, CEO at Generate:Biomedicines - a pioneer in generative biology that is transforming the way medicines are developed. Over this fascinating conversation, Mike shared his thoughts on the AI-driven drug development landscape and how data is set to change the way every drug is made in the future. We covered: → The latest in drug development trends, from how the availability of data accelerates what is possible to breakthroughs in de novo generation that allow proteins to be developed with unprecedented specificity. → Mike's view on the current status of machine learning's role in biotech R&D and how this will evolve. → How Generate innovates at each phase of AI-driven drug development. → And the value of Chroma, an open-source diffusion model from Generate that allows scientists to push the boundaries of protein discovery. Check it out on Apple, Spotify or wherever you get your podcasts. Apple: https://lnkd.in/e8y_hNUJ Spotify: https://lnkd.in/e8-K6KFu #data #biotech #drugdevelopment

Our CEO Michael Nally is featured on CorrDyn’s latest Data in Biotech podcast with Ross Katz, where he discusses how we are transforming drug development using #GenerativeAI. As an example, Mike shares: "The phase 1 data for GB-0669 [a monoclonal antibody targeting the S2 stem helix in SARS-CoV-2] has shown a significant improvement in safety and efficacy, which paves the way for our next stages of development. Our approach leverages #GenerativeBiology to design proteins that precisely target the intended conditions, thus reducing potential side effects and increasing therapeutic effectiveness." Want to hear more? Mike also discusses Chroma, our generative model for protein design, our culture, and our values of being audaciously ambitious, intrinsically digital, and patient-first, among other exciting topics. Listen to the full episode below 👇 #TeamGenerate | #ProteinEngineering

Our latest episode of the Alldus, “AI in Action” Podcast features Drew Linsley from Operant Biopharma. Here Drew talks us through his journey and how Operant are using AI to autonomously design biological experiments, discovering and optimizing disease treatments. It’s another example of the groundbreaking work across the AI world. If you are a business leader doing innovative work in AI and would be interested in featuring on the podcast, we’d love to hear from you. #biopharma #artificialintelligence #aiinaction

CIO at Absci answer tough questions and shares the value generative-AI is providing in drug development today. 🏥 @Absci Andreas Busch, PhD, recently joined @Oracle Life Sciences' Latest Dose podcast to discuss how AI is shaping the future of #drugdevelopment. Listen here. https://lnkd.in/eM2XYaJm 🏥

Tune in to Episode 2 of ACRO's Good Clinical Podcast, where Stephen Pyke and the FDA's Dr. Tala Fakhouri discuss the massive potential of AI in clinical research. 🎙   Learn more about the FDA's evidentiary standards for AI, the importance of methodological transparency in submissions and how AI stands to streamline the drug development process, helping to bring life-changing medicines to market more efficiently. 💡 Stephen also sheds light on where AI advancements will show up and what it means for patients. 👇 Watch below! Don’t miss this fascinating discussion. Access the full episode here: https://lnkd.in/gdMz_agR #ACRO #GoodClinicalPodcast #ArtificialIntelligence